RESTYLANE® EYELIGHT™ is an injectable dermal filler used specifically for the correction of infraorbital hollows in patients over the age of 21. It contains hyaluronic acid (HA) crosslinked with BDDE (1.4-butanediol diglycidyl ether) and is designed to reduce the appearance of hollowing under the eyes, providing a more refreshed and youthful look. The presence of lidocaine (0.3%) helps to alleviate discomfort during injection.

Key Indications:

• Treatment of infraorbital hollows (under-eye hollowing).
• Provides volume restoration and correction in the periorbital area.

Dosage Information

The product comes as a sterile gel in a 1 ml syringe, with a concentration of 20 mg/mL of hyaluronic acid and 0.3% lidocaine. It is intended for use with a 29G needle or 25G-27G cannula, administered by a trained healthcare professional.

RESTYLANE® EYELIGHT™ Dosage Summary:

• Hyaluronic Acid Concentration: 20 mg/mL.
• Lidocaine Concentration: 0.3%.
• Syringe Volume: 1 ml.
• Recommended injection volume: Maximum of 1 mL per side per treatment session. If more than 1 mL is needed, a follow-up session is recommended.

The injection should be performed in the supraperiosteal plane for best results, and the infraorbital hollows are treated by placing the filler beneath the skin in a linear threading or fanning technique.